The spread of HIV in China has lasted for over 20 years, and is marked by three periods: sporadic period (1984-1988), localized epidemic period (1989-1994), rapid growth period (1995-present). In the end of July 2007, the cumulative reported cases living with HIV/AIDS were 214, 300. By 2005, the dominant modes of HIV transmission were sexual contact and IDU, although FBD/PBD account for a significant proportion of people living with HIV. The epidemic is spreading from high-risk groups to the general population, and there is a potential risk that the epidemic will spread further. Fortunately, China has initiated a number of policies and strategies including free HARRT policy, the treatment and care to many HIV-infected victims then is ensured.
In the battle against HIV/AIDS, Chinese pioneers have made great contributions. Ever since the first HIV case was identified in China in 1985, Chinese researchers have been tracking this mysterious virus closely. In 1987, China isolated the HIV from a foreign patient in Yunnan Province for the first time. Afterwards, China's research groups have put tremendous efforts into many comprehensive HIV studies, along with the full support from the government of all level. China is making rapid progress in fighting against HIV/AIDS; however, there are still many obstacles: high-risk behavior that leads to HIV/AIDS is increasing significantly; more and more fluid population is shifting from villages to metropolis, from high-prevalence regions to low-prevalence regions; HIV drug resistance is raising, etc. Facing these complexes, researchers feel that it is urgent to initiate wider range collaboration and to speed up the invention of HIV vaccine, new ARVs and prevention methods in China.
The destination of this issue of AIDS is to document the present status of HIV/AIDS in China; to thoroughly reflect China's current HIV/AIDS research progress for the future reference. For this purpose, we have invited, with great honor, many world and domestic renowned experts and specialists, include Academician, chief scientists, government leaders, leading experts of the field, to compose most high quality and advanced articles for our readers. They have provided excellent overviews and dissertations in macro and micro aspects, which contain general introductions and following specific topics: HIV epidemiology, virology, drug resistance, antibody research, HIV/HCV co-infection, TCM, antiviral drugs, immunology, clinical treatment and pathology, animal model, quality control and government network. Almost every topic is covered, and we are extremely happy to see this volume becoming a comprehensive collection of HIV/AIDS. A few years from now, we will publish the second issue as a follow-up to record the development in HIV/AIDS research and China's progress with full consciousness of responsibility.
As a HIV researcher, a writer and concurrently associate Editors-in-Chief of Virologica Sinica, I hereby would like to thank and send my regards to all the writers and editors, who have made enormous contribution to this issue. Moreover, with the full support of the leading researchers in HIV/AIDS or other virological fields, Virologica Sinica will step steadily forward to PubMed, to be recognized by SCI and of making Virologica Sinica one of the best Chinese virological journals.
Now, Chinese researchers are racing against the time. There may be barriers and obstacles lying ahead, but we will not give up our hope and faith: that with joint efforts and extensive collaboration, China's HIV epidemic will finally be contained and we eventually will defeat this vigorous virus.
HIV/AID Research in China: Chasing against Time
- Received Date: 07 November 2007
- Accepted Date: 10 November 2007